Target intelligence / Profile preview

Long intergenic non-protein coding RNA 112 (LINC00112)

Target
LINC00112
Molecular classification
Other (non-coding RNA, specifically long intergenic non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 112 (LINC00112) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as transcripts longer than 200 nucleotides that do not code for proteins and do not overlap annotated protein-coding genes[1]. LincRNAs as a class are increasingly recognized for diverse regulatory functions, including chromatin remodeling, transcriptional and post-transcriptional gene regulation, and cellular homeostasis[3][5]. While some lincRNAs have been linked to disease processes such as cancer, cardiovascular, and neurodegenerative diseases, there is currently no direct evidence establishing LINC00112 itself as a validated therapeutic target, nor are there known drugs or biomarker functions specific to LINC00112[1]. LINC00112 may be studied in certain molecular or functional genomics projects, but its individual functional roles remain largely uncharacterized.

Other names
C21orf22NCRNA00112LINC00112
02

Biological functions

Gene regulationPossible involvement in cell cycle or cell proliferation (by analogy to lincRNAs in general)
03

Disease associations

Cancer (lincRNAs often implicated in cancer)Other diseases possible but not specifically documented for LINC00112
04

Biomarkers

Non-coding RNAs including LINC00112 may serve as biomarkers, but LINC00112-specific biomarker status not established

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 112 (LINC00112).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 112 (LINC00112).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call